Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUTERA INCCUTR · Entity 82936 | Director | October 24, 2024 | November 05, 2024 |
| Sientra, Inc.SIEN · Entity 108294 | Director | June 09, 2022 | June 14, 2022 |
| Venus Concept Inc.VERO · Entity 55304 | Director | March 24, 2023 | March 28, 2023 |
| Zeltiq Aesthetics IncZLTQ · Entity 176636 | CCO, President, North America | January 04, 2017 | January 06, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUTERA INC
Report date October 24, 2024 · Filed November 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.65 · Expires 2031-10-23 | Direct | 20,000 |
Reported balance
After 2024-10-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-24 · Grant · Acquired 20,000 · Balance 20,000 F1: All shares vest on the earlier of 12 months from grant date, or on the day of the 2025 annual stockholder meeting, subject to the Reporting Person continuing to be a service provider of the Company. F2: The expiration date is subject to earlier expiration upon the termination of the Reporting Person's service with the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: All shares vest on the earlier of 12 months from grant date, or on the day of the 2025 annual stockholder meeting, subject to the Reporting Person continuing to be a service provider of the Company.
F2: The expiration date is subject to earlier expiration upon the termination of the Reporting Person's service with the Company.
Sientra, Inc.
Report date June 09, 2022 · Filed June 14, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 370,354 |
Reported balance
After 2022-06-09 transaction · row 1
1 source rowRow 1 · 2022-06-09 · Grant · Acquired 103,306 · Balance 370,354 F1: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service.
Venus Concept Inc.
Report date March 24, 2023 · Filed March 28, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.19 · Expires 2033-03-24 | Direct | 75,000 |
Reported balance
After 2023-03-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-24 · Purchase · Acquired 75,000 · Balance 75,000 F1: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date.
Zeltiq Aesthetics Inc
Report date January 04, 2017 · Filed January 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,198 |
Ending reported balance
After 2017-01-04 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2017-01-04 · Exercise / conversion · Acquired 8,000 · Balance 87,198 Row 2 · 2017-01-04 · Sale · Disposed 7,700 · Balance 79,498 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 3 · 2017-01-04 · Sale · Disposed 100 · Balance 79,398 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 4 · 2017-01-04 · Sale · Disposed 100 · Balance 79,298 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Row 5 · 2017-01-04 · Sale · Disposed 100 · Balance 79,198 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.21 · Expires 2022-10-04 | Direct | 74,000 |
Reported balance
After 2017-01-04 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-01-04 · Exercise / conversion · Disposed 8,000 · Balance 74,000 F3: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Keith J Sullivan (IRA) FCC as custodian | 5,000 |
Reported balance
Holding disclosure · report date 2017-01-04 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 5,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Neuronetics, Inc.
Report date March 19, 2026 · Filed March 24, 2026
Section 16 reporting ended · disclosed 2026-03-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,590,924 |
Reported balance
After 2026-03-19 transaction · row 1
1 source rowRow 1 · 2026-03-19 · Sale · Disposed 46,289 · Balance 1,590,924 F1: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a performance restricted stock unit award.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.48 to $1.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2020 Filed Feb 5, 2021 22:25 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000078 · edgar.xml · derivative · entry 3 Sullivan Keith J · CIK 0001417973 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 500,000 shares Expires not disclosed F3 · derivative.exercise_price: Effective as of July 14, 2020, Mr. Sullivan received 500,000 PRSUs, which vest ratably based on appreciation of the Issuer's common stock price to $10, $15, $20 and $25 per share, measured using a trailing 30-day volume weighted average price of a share of the Issuer's common stock. Mr. Sullivan has vested 250,000 PRSUs to date. F3 · derivative.exercise_date: Effective as of July 14, 2020, Mr. Sullivan received 500,000 PRSUs, which vest ratably based on appreciation of the Issuer's common stock price to $10, $15, $20 and $25 per share, measured using a trailing 30-day volume weighted average price of a share of the Issuer's common stock. Mr. Sullivan has vested 250,000 PRSUs to date. F3 · derivative.expiration_date: Effective as of July 14, 2020, Mr. Sullivan received 500,000 PRSUs, which vest ratably based on appreciation of the Issuer's common stock price to $10, $15, $20 and $25 per share, measured using a trailing 30-day volume weighted average price of a share of the Issuer's common stock. Mr. Sullivan has vested 250,000 PRSUs to date. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 22:40 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 27,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035385 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,178 F1 · shares: The Restricted Stock Units (RSUs) will vest on the earlier to occur of: (i) the day prior to the Annual Meeting for the fiscal year following the date of grant or (ii) the one (1) year anniversary of the Annual Meeting on which the Annual Grant was granted, subject to continued service as a director of the Issuer. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:51 UTC | Venus Concept Inc. VERO · Entity 55304 | GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.64 | $0.00 |
DisclosureSEC source: 0001382963-20-000051 · edgar.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-03-30 F1 · derivative.exercise_date: The options vest with respect to 1/16th of the underlying Common Stock on each quarterly anniversary of the date of grant, subject to continued service through each applicable vesting date. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:22 UTC | Venus Concept Inc. VERO · Entity 55304 | SaleCommon Stock | 7,184 | $2.91 | $20,905.44 |
DisclosureSEC source: 0001382963-19-000152 · edgar.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,133 F1 · shares: This sale was and the sales transacted on December 3, 2019 and December 4, 2019, which were previoulsy reported on a Form 4 filed by the reporting person on December 5, 2019, were intended to cover the payment of taxes, including estimated taxes, in connection with the vesting of the 33,333 shares of common stock set forth on the previous Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 21:22 UTC | Venus Concept Inc. VERO · Entity 55304 | SaleCommon Stock | 100 | $2.80 | $280.00 |
DisclosureSEC source: 0001382963-19-000152 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,317 F1 · shares: This sale was and the sales transacted on December 3, 2019 and December 4, 2019, which were previoulsy reported on a Form 4 filed by the reporting person on December 5, 2019, were intended to cover the payment of taxes, including estimated taxes, in connection with the vesting of the 33,333 shares of common stock set forth on the previous Form 4. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 23:18 UTC | Venus Concept Inc. VERO · Entity 55304 | SaleCommon Stock | 200 | $3.15 | $630.00 |
DisclosureSEC source: 0001382963-19-000150 · edgar.xml · nonDerivative · entry 3 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,417 Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 23:18 UTC | Venus Concept Inc. VERO · Entity 55304 | SaleCommon Stock | 5,716 | $3.26 | $18,634.16 |
DisclosureSEC source: 0001382963-19-000150 · edgar.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,617 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.22 to $3.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2019 Filed Dec 5, 2019 23:18 UTC | Venus Concept Inc. VERO · Entity 55304 | GrantCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001382963-19-000150 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,333 F1 · balance_after: On November 7, 2019, the common stock of the Issuer went through a 1-for-15 reverse stock split, resulting in the reporting person's ownership of 24,000 shares of Common Stock prior to this transaction. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 23:55 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 19,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-037851 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,461 F1 · shares: The Restricted Stock Units (RSUs) will vest on the earlier to occur of: (i) the day prior to the Annual Meeting for the fiscal year following the date of grant or (ii) the one (1) year anniversary of the Annual Meeting on which the Annual Grant was granted, subject to continued service as a director of the Issuer. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:45 UTC | Sientra, Inc. SIEN · Entity 108294 | PurchaseCommon Stock | 20,869 | $5.75 | $119,996.75 |
DisclosureSEC source: 0001209191-19-036104 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,141 Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 01:50 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034100 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · Strategic Consultant 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,272 F1 · shares: The Restricted Stock Units (RSUs) vest in equal quarterly installments beginning on the first business day following the quarter ending March 31, 2019 subject to the Reporting Person's continued service. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 22:22 UTC | Venus Concept Inc. HAIR · Entity 55304 | GrantCommon Stock | 360,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-005863 · doc1.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 06, 2018 Filed Aug 9, 2018 01:15 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001209191-18-045945 · doc4.xml · derivative · entry 2 Sullivan Keith J · CIK 0001417973 · Director · Interim GM miraDry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F2 · derivative.exercise_date: The performance-based RSUs shall vest upon the achievement of certain performance objectives on the first business day after the Issuer files its Annual Report on Form 10-K for the financial year ending December 31, 2018, subject to the Reporting Person's continued service. F2 · derivative.expiration_date: The performance-based RSUs shall vest upon the achievement of certain performance objectives on the first business day after the Issuer files its Annual Report on Form 10-K for the financial year ending December 31, 2018, subject to the Reporting Person's continued service. Read SEC document |
| August 06, 2018 Filed Aug 9, 2018 01:15 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 35,000 | $20.97 | $733,950.00 |
DisclosureSEC source: 0001209191-18-045945 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director · Interim GM miraDry 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,272 F1 · shares: The Restricted Stock Units (RSUs) vest immediately following the filing of the Issuer's quarterly report on Form 10-Q for the period ending June 30, 2018. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 23:02 UTC | Venus Concept Inc. HAIR · Entity 55304 | GrantStock Option (Right to Buy) · Derivative | 27,417 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0001140361-18-031698 · doc1.xml · derivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,417 Underlying: Common Stock · 27,417 shares Expires 2028-07-02 F1 · derivative.exercise_date: The option vests with respect to 1/36 of the shares subject thereto on each monthly anniversary of July 2, 2018, subject to continued service on the board of directors through each applicable vesting date. Read SEC document |
| June 05, 2018 Filed Jun 8, 2018 00:40 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 6,116 | $20.44 | $125,011.04 |
DisclosureSEC source: 0001209191-18-036544 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,272 F1 · shares: The Common Stock underlying this grant of restricted stock will vest on the earlier to occur of: (i) the day prior to the annual meeting of stockholders for the year following the date of grant or (ii) the one (1) year anniversary of the annual meeting of stockholders of the year of grant, subject to continued service as a director of the Issuer. Read SEC document |
| May 07, 2018 Filed May 9, 2018 21:10 UTC | Sientra, Inc. SIEN · Entity 108294 | PurchaseCommon Stock | 7,407 | $13.50 | $99,994.50 |
DisclosureSEC source: 0001209191-18-028917 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,156 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 18:15 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSUs) | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019505 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,749 F1 · shares: The Restricted Stock Units (RSUs) will vest in arrears in four quarterly installments as follows: (i) 10,000 shares shall vest on the first business day after the quarter ending March 31, 2018; (ii) 10,000 shares shall vest on the first business day after the quarter ending June 30, 2018; (iii) 10,000 shares shall vest on the first business day after the quarter ending September 30, 2018; and (iv) 10,000 shares shall vest on the first business day after the quarter ending December 31, 2018. The RSUs vesting will be pro-rated for any partial quarter of engagement as a consultant during the Term and vesting shall be subject to the Reporting Person's continued service as a consultant. Read SEC document |
| August 04, 2017 Filed Aug 9, 2017 00:00 UTC | Sientra, Inc. SIEN · Entity 108294 | GrantCommon Stock (RSU) | 13,749 | $10.91 | $150,001.59 |
DisclosureSEC source: 0001179110-17-011247 · edgar.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,749 F1 · shares: Reporting Owner was granted a restricted stock unit award on August 4, 2017 having a value equal to $150,000 based on the closing price per share of the Company's common stock on August 4, 2017, which will vest in a series of three equal annual installments subject to Reporting Owner's continuous service. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 02:07 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001209191-17-002446 · doc4.xml · derivative · entry 7 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 8,000 shares Expires 2022-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 02:07 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 100 | $44.91 | $4,491.00 |
DisclosureSEC source: 0001209191-17-002446 · doc4.xml · nonDerivative · entry 5 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,198 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 02:07 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 100 | $44.90 | $4,490.00 |
DisclosureSEC source: 0001209191-17-002446 · doc4.xml · nonDerivative · entry 4 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,298 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 02:07 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 100 | $44.89 | $4,489.00 |
DisclosureSEC source: 0001209191-17-002446 · doc4.xml · nonDerivative · entry 3 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,398 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 02:07 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 7,700 | $44.34 | $341,392.59 |
DisclosureSEC source: 0001209191-17-002446 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,498 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.86 to $44.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 02:07 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionCommon Stock | 8,000 | $6.21 | $49,680.00 |
DisclosureSEC source: 0001209191-17-002446 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 18:11 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001209191-16-153569 · doc4.xml · derivative · entry 4 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 Underlying: Common Stock · 8,000 shares Expires 2022-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 18:11 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 8,000 | $43.78 | $350,211.20 |
DisclosureSEC source: 0001209191-16-153569 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,198 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.58 to $44.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 05, 2016 Filed Dec 6, 2016 18:11 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionCommon Stock | 8,000 | $6.21 | $49,680.00 |
DisclosureSEC source: 0001209191-16-153569 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 17:22 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Tax withholdingCommon Stock | 4,195 | $39.58 | $166,038.10 |
DisclosureSEC source: 0001209191-16-149606 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,780 F2 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy the tax withholding obligation that arose in connection with the vesting of the PSUs. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 17:22 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-149606 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,975 F1 · shares: Represents the number of shares issued upon vesting of Performance Stock Units awarded on 2/29/16 ("PSUs"). Read SEC document |
| November 06, 2016 Filed Nov 7, 2016 21:56 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Tax withholdingCommon Stock | 1,048 | $34.06 | $35,694.88 |
DisclosureSEC source: 0001209191-16-148664 · doc4.xml · nonDerivative · entry 3 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,975 F3 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy the tax withholding obligation that arose in connection with the vesting of the Restricted Stock Units ("RSUs"). The RSUs for 10,000 shares vest in four equal annual installments beginning on the first anniversary of November 6, 2014. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 21:56 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001209191-16-148664 · doc4.xml · derivative · entry 5 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 8,000 shares Expires 2022-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 21:56 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 8,000 | $33.01 | $264,058.40 |
DisclosureSEC source: 0001209191-16-148664 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,023 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.63 to $33.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 21:56 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionCommon Stock | 8,000 | $6.21 | $49,680.00 |
DisclosureSEC source: 0001209191-16-148664 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 20:35 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001209191-16-145243 · doc4.xml · derivative · entry 5 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,000 Underlying: Common Stock · 8,000 shares Expires 2022-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 20:35 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Tax withholdingCommon Stock | 568 | $39.01 | $22,157.68 |
DisclosureSEC source: 0001209191-16-145243 · doc4.xml · nonDerivative · entry 3 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,023 F3 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy the tax withholding obligation that arose in connection with the vesting of the Restricted Stock Units ("RSUs"). The RSUs for 65,000 shares vest as follows: 25% of the total number of shares subject to the RSUs vested on October 4, 2013 and the remainder vests in 36 equal monthly installments. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 20:35 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 8,000 | $38.84 | $310,719.20 |
DisclosureSEC source: 0001209191-16-145243 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,591 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.63 to $39.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 20:35 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionCommon Stock | 8,000 | $6.21 | $49,680.00 |
DisclosureSEC source: 0001209191-16-145243 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 15:37 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0001209191-16-140360 · doc4.xml · derivative · entry 4 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 Underlying: Common Stock · 8,000 shares Expires 2022-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total number of shares subject to the option vested on October 4, 2013, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 15:37 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | SaleCommon Stock | 8,000 | $38.36 | $306,867.20 |
DisclosureSEC source: 0001209191-16-140360 · doc4.xml · nonDerivative · entry 2 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,159 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.09 to $38.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 15:37 UTC | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Exercise / conversionCommon Stock | 8,000 | $6.21 | $49,680.00 |
DisclosureSEC source: 0001209191-16-140360 · doc4.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2016 Filed Oct 6, 2016 20:34 UTC Amendment | Zeltiq Aesthetics Inc ZLTQ · Entity 176636 | Tax withholdingCommon Stock | 568 | $38.07 | $21,623.76 |
DisclosureSEC source: 0001209191-16-145242 · doc4a.xml · nonDerivative · entry 1 Sullivan Keith J · CIK 0001417973 · CCO, President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,591 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer to satisfy the tax withholding obligation that arose in connection with the vesting of the Restricted Stock Units ("RSUs"). The RSUs for 65,000 shares vest as follows: 25% of the total number of shares subject to the RSUs vested on October 4, 2013 and the remainder vests in 36 equal monthly installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.